Insiders Summit Therapeutics Inc.

Equities

SMMT

US86627T1088

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 17:44:11 10/02/2026 GMT			5-day change	1st Jan Change
15.41 ^USD	+2.94%		+6.03%	-11.55%

01-29	Sector Update: Health Care Stocks Edge Higher Premarket Thursday	MT
01-29	Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy	CI

Insiders

02-09	Avacta appoints new chief scientific officer, plans clinical trials	AN
02-09	Avacta Therapeutics Announces Executive Changes	CI
24/10/25	Summit Therapeutics Insider Bought Shares Worth $9,999,983, According to a Recent SEC Filing	MT
12/09/25	Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing	MT
12/09/25	Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing	MT
18/03/25	Summit Therapeutics Names Robert LaCaze as Chief Commercial Officer	MT
17/03/25	Robert LaCaze Joins Summit Therapeutics Inc. as Chief Commercial Officer	CI
27/06/24	Summit Therapeutics Inc. Appoints Jeff Huber to Its Board of Directors	CI
24/06/24	Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer	CI
24/06/24	Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Chief Financial Officer	CI
13/06/24	Summit Therapeutics Inc. Announces Resignation of Ujwala Mahatme as Member of its Board	CI
11/04/24	Summit Therapeutics Inc. Appoints Dr. Mostafa Ronaghi to Its Board of Directors	CI
09/04/24	Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	RE
09/04/24	Illumina Names Ankur Dhingra as Chief Financial Officer	MT
09/04/24	Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor	RE
04/04/24	Summit Therapeutics Appoints COO to Additional Role of CFO	MT
03/04/24	Summit Therapeutics Inc. Appoints Bhaskar Anand as Chief Accounting Officer, Head of Finance, to Serve as Its Principal Accounting Officer	CI
28/03/24	Summit Therapeutics Insider Bought Shares Worth $375,000, According to a Recent SEC Filing	MT
02/11/23	Laura Chow Joins Summit Therapeutics Inc. as Senior Vice President of Clinical Development	CI
16/10/23	Summit Therapeutics Insider Bought Shares Worth $4,999,999, According to a Recent SEC Filing	MT
16/10/23	Summit Therapeutics Names Manmeet Soni as Chief Operating Officer	MT
16/10/23	Summit Therapeutics Inc. Announces Management Changes	CI
09/03/23	Insider Buy: Summit Therapeutics	MT
08/03/23	Insider Buy: Summit Therapeutics	MT
08/03/23	Insider Buy: Summit Therapeutics	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Insiders Summit Therapeutics Inc.

Equities

SMMT

US86627T1088

Biotechnology & Medical Research

Insiders

Filters